⏰ Last chance to submit your abstract for Signalling Circuits in Cancer! Don’t miss your opportunity to be part of this exciting new conference topic. If your work explores oncogenic signalling, cellular communication networks, this is the perfect platform to showcase your research.

Glad to share our latest perspective published on @natcomms.nature.com, trying to push #DTP research to a new frontier. Thanks to very helpful and constructive suggestions from the reviewers and editors!

Our journal @oncogenesisnature.bsky.social is officially on Bluesky, follow us to know more about frontier oncological advances

One month left to register for the 2025 Early Career Researchers Conference! In its fifth edition, this virtual conference has become a must-attend for early career researchers to discuss critical aspects of a scientific career in cancer research. Don't miss it: eacr.org/conference/e...

Join this fzntastic meeting in beautiful Lisboa @helloeacr.bsky.social

The EACR stands against threats to cancer research. Protecting scientific research is vital for progress and and the development of new treatments. Read our full statement in support of our friends and colleagues in the US: eacr.org/statement-on...

EACR members, you're invited to join us for an in-depth discussion on securing cancer research funding! Chat with our expert guest speakers about funding opportunities, grant writing, interview strategies and more in this interactive workshop. 📅 10 March 12:00 CET us02web.zoom.us/meeting/regi...

Highly recommend this nice work published on Cancer Discovery that we are honored to write a View in the context of EMT @theaacr.bsky.social

It is not Nash’s game theory . Defense -attack, we do not want zero-sum game, we wanna the best attack by defense. Join this wonderful meeting in Barcelona with @helloeacr.bsky.social

Wanna meet experts in drug tolerant persister cells? Learn more about the frontiers of cancer cell plasticity and minimal residual diseases, come to join us in Lyon France for this @helloeacr.bsky.social EACR conference!

In the year of Snake 🐍 2025, join us @helloeacr.bsky.social in beautiful Lisboa for a prosperous year of EACR congress!

MIF is the devil 😈 in detail of low intra-tumoral heterogeneous cancer that evade immune surveillances. aacrjournals.org/cancerdiscov...

It was a fun to bring together reflections from researchers across various fields on inspiring cancer studies in 2024

The waltz between metabolism and mRNA translation. Find out our new insight on this interaction between two essential cellular adaptive responses to stresses. authors.elsevier.com/c/1kAJt3QxxS...

Life is short, Carpe Diem by ribosomes 🙆 @cellpress.bsky.social #ribosomes www.cell.com/cell/fulltex...

The AACR Cancer Progress Report 2024 highlights research-driven advances in cancer science and medicine. Read the Report: CancerProgressReport.org  #CancerProgressReport

Did you catch our latest podcast episode? 🎧 Tune in for an insightful conversation with the authors of a recent Nature Cancer article on a novel pan-lysyl oxidase inhibitor in #PancreaticCancer. magazine.eacr.org/a-novel-pan-...

Join us at the EACR-Boehringer Ingelheim virtual conference @EACR on Drugging and Regulating the MAP Kinase Pathway (11-12 February 2025) where we will assess the basic and clinical aspects of the regulation of signaling through the MAPK pathway and its role in cancer. eacr.org/conference/b...

Ribosomes are heterogenous and long believed immunoribosome revealed by this study that P-Stalk ribosome responds to inflammatory cues and alert 🚨 cell immune response. www.cell.com/cell/fulltex...

Too often we spend only two weeks choosing a problem and then many years trying solving it, but this limits our potential impact. A must read for PhD students: Problem choice and decision trees in science and engineering. pubmed.ncbi.nlm.nih.gov/38608651/

Shifting from X to BlueSky, first tweet 🐣 maybe our recent roadmap will let you know better what we are working on in the lab 🧫 link: www.nature.com/articles/s41...